Tag Archives: Wall Street Journal

Merck, Schering-Plough Merger Boosts Global Profile, but Questions Linger

By Andrew Sheivachman | Published: November 5, 2009
Image via Wikipedia After Merck & Co. officially announced its $41.1 billion merger with Schering-Plough yesterday, CEO Richard Clark made it clear his company is still looking to expand through further acquisitions and mergers. According to the Wall Street Journal’s Health Blog: Clark told us today that the newly combined company  is “actively looking” for biotechs to [...]
Posted in Strategy | Also tagged , , , , , , | 2 Comments

Woodcock Under Investigation

By George Koroneos | Published: August 12, 2009
Image by Getty Images via Daylife An FDA director has come under fire by a generics firm claiming that the director of the Center for Drug Evaluation and Research favored a competitor in a wanton act of conflict of interest. The Wall Street Journal this morning broke the story that Janet Woodcock is under investigation by [...]
Posted in Strategy | Also tagged , , , , , | Leave a comment

Judge Throws The Book At Former Bristol-Myers Squibb Exec

By Walter Armstrong | Published: June 9, 2009
Media wordsmiths are competing to outdo one another today in punny reporting on the news that ex-BMS exec Andrew Bodnar has been sentenced to write a book about the role he played in the firm’s 2006 reverse-payments case over generic Plavix. “Pen-ance: Bristol-Myers Exec Gets Two Years of Hard Writing,” The Wall Street Journal Law Blog [...]
Posted in Legal | Also tagged , , , , , , , | Leave a comment